Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
71.93
+2.70 (+3.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Cathie Wood Onto 'Next Thing' In AI After ARK's Nvidia Exit: What's On Her Radar?
May 31, 2023
Via
Benzinga
3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year
May 25, 2023
Is it too late to buy these rebounding stocks?
Via
The Motley Fool
MarketBeat Week in Review – 5/15 - 5/19
May 20, 2023
Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities
Via
MarketBeat
Topics
Economy
Electric Vehicles
Exposures
Economy
Electric Vehicles
Interest Rates
3 AI Stocks That Famed Investor Cathie Wood Is Betting On
May 16, 2023
Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too.
Via
InvestorPlace
Why Exact Sciences Stock Roared Higher This Week
May 11, 2023
The cancer diagnostic company's Q1 report was full of good news for shareholders.
Via
The Motley Fool
Expert Ratings for Exact Sciences
May 11, 2023
Via
Benzinga
Why Shares of Exact Sciences Rose on Wednesday
May 10, 2023
The diagnostic testing company announced strong first-quarter earnings.
Via
The Motley Fool
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The
Via
MarketBeat
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.
Via
InvestorPlace
A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 164%, According to Wall Street
May 14, 2023
This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right.
Via
The Motley Fool
Cathie Wood's Flagship ARK ETF Marks 5-Day Winning Streak — Outperforming Nasdaq, FAANG In May
May 11, 2023
Cathie Wood's flagship fund Ark Innovation ETF (ARCA: ARKK) marked a five-day winning streak on Wednesday for the first time since January, as a lower-than-expected U.S.
Via
Benzinga
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
May 09, 2023
EXAS earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Exact Sciences Guidance Beat Street View, Analyst Says Company Fires All Cylinders
May 10, 2023
Exact Sciences Corp's (NASDAQ: EXAS) Q1 revenues increased 24% Y/Y to $602 million, beating the average Wall Street esti
Via
Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
A New Groundbreaking Tool to Detect Colon Cancer Earlier
May 10, 2023
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...
Via
PressReach
Exposures
Product Safety
EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates
May 09, 2023
EXAS stock posted Q1 results that include a loss per share of 42 cents and revenue that was much better than analysts expected.
Via
InvestorPlace
Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer
May 09, 2023
The company sells Cologuard, a test to screen for colon cancer.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
May 05, 2023
Via
Benzinga
3 Stocks That AI Predicts Will Outperform the Market
May 04, 2023
Here are three stocks that came up when I asked the generative AI chatbot that powers Bing chat to make some AI stock recommendations
Via
InvestorPlace
New Artificial Intelligence Tool Can Diagnose Colon Cancer
May 03, 2023
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...
Via
PressReach
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Product Safety
The 7 Best Biotech Stocks for Personalized Medicine Investors
April 25, 2023
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics.
Via
InvestorPlace
Cathie Wood’s Next Big Bet: 3 Disruptive Innovations to Watch
April 24, 2023
These Cathie Wood stocks could deliver massive gains in the coming years as they disrupt traditional industries.
Via
InvestorPlace
What Has Cathie Wood Been Trading?
April 19, 2023
The story of Ark Invest, Wall Street veteran Cathie Wood’s lineup of actively managed, innovation-centric ETFs is well-known at this point. Ark has been defined by big bets, big wins, big losses, and...
Via
Benzinga
2 Supercharged Growth Stocks That Could Rocket 116% to 899% Higher, According to Wall Street
April 15, 2023
Find out why expectations are so high for these two innovative businesses.
Via
The Motley Fool
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire.
Via
InvestorPlace
3 Cathie Wood Stocks for Your April Must-Buy List
April 04, 2023
Cathie Wood stocks are doing much better in 2023 than last year. Here are three to put on your April must-buy list.
Via
InvestorPlace
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
April 03, 2023
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell.
Via
Investor's Business Daily
3 Stocks With Superior Potential for Super-Sized Gains in 2023
March 22, 2023
Investing in stocks with potential is a great way to make money as long as you do your research and understand the risks involved.
Via
InvestorPlace
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have Today
March 16, 2023
Has this been a market-beating investment?
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.